Articles

Wearing a rigid gas permeable lens can lead to improved topographic parameters and can significantly alter a number of study parameters.

Administering 5% povidone-iodine for 15 minutes or 10% povidone-iodine for 5 minuytes can contribute towards the prevention of the growth of endophthalmitis bacterial isolates.

Pancorneal toric rigid gas-permeable (RGP) lens fitted in keratoconus eyes greatly improves best-corrected visual acuity (BCVA) and keratometric values.

Using twenty-gauge transconjunctival sutureless vitrectomy in vitreoretinal surgery is a safe and effective treatment for a variety of vitreoretinal pathologies

Conjunctival S.epidermidis. repeatedly exposed to fluoroquinolone or azithromycin antibiotics quickly develops resistance in patients undergoing serial unilateral intravitreal (IVT) injections for choroidal neovascularization

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved.

Increased donor graft size, younger donor age, and being female donor were linked to higher endothelial cell density (ECD) in patients who underwent penetrating keratoplasty for endothelial dysfunction conditions

Imiquimod (IMQ) 5% cream and radiotherapy (RT) are both effective for treating periocular nodular-based cell carcinoma (BCC)

Implantation of toric multifocal IOL in patients with cataract and corneal astigmatism provides good distance and near visual outcomes and spectacle independence.

Descemet-stripping automated endothelial keratoplasty (DSAEK) efficiently restores corneal clarity with minimal complications in young congenital hereditary endothelial dystrophy (CHED) patients

The latanoprost punctual plug delivery system (L-PPDS) is a safe and effective way of administering glaucoma medication, according to ocular company QLT.

According to data recently published, repeated use of ophthalmic antibiotics post intraocular injections will cause an increase in incidences of resistant strains of conjunctival flora.

The Max Planck Society (Max-Planck-Gesellschaft) and Fovea Pharmaceuticals (the ophthalmology division of Sanofi) have announced the formation of a partnership to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.

New research from the University of Cardiff's School of Optometry and Vision Sciences has been announced that is hoped to establish new evidence into the link between visual impairment and depression.

Bausch + Lomb and Technolas Perfect Vision have announced the release of the VICTUS femtosecond laser platform at this year's ESCRS meeting in Vienna, Austria.

Through the use of next-generation DNA sequencing techniques, researchers from the University of Leeds have discovered the causes of rare forms of inherited eye disorders in paediatric patients.

Novagali Pharma has announced positive results from its Phase II trial of the preservative-free cationic emulsion, Catioprost.

The CE mark of approval has been given to OptiMedica's Catalys Precision Laser System.

Amakem has raised €18 million to go towards the development of highly potent kinase (ROCK) inhibitor AMA0076.

The KAMRA inlay (AcuFocus) is an effective, safe and reversible technique for the long-term surgical treatment of presbyopia.

Cycloisporine A (CSA) 1% eye drops could be an effective corticosteroid-sparing agent for treating symptomatic corneal subepithelial infiltrates (SEI) after adenoviral keraconjunctivitis (AK).

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.

Differences in nerve fibre layer (NFL) in the macular area can be easily detected using a modified optical coherence tomography (OCT) scanning technique.

Decreased tear levels of neuropeptide Y (NPY) and calcitonin gene?related peptide (CGRP) are linked to damaged tear function.

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients.

A combination of scleral buckling and vitrectomy produced better anatomical success rates and fewer operative procedures in surgery for primary retinal detachment patients.

An investigation in the Journal of Cataract and Refractive Surgery strongly suggests the use of fortified antibiotic agents for prevention of vision loss in infectious keratitis patients.

New ophthalmic company KalVista Pharmaceuticals has generated £8 million from series A contributed by Novo A/S and SV Life Sciences.

Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.

Luminous, a program created to develop the understanding of retinal vascular diseases, has enrolled its first patient this month.